Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7.

Published

Journal Article

In the present work, we described the design, synthesis and biological evaluation of a novel series of potential dual-target prodrugs targeting the HIV-1 reverse transcriptase (RT) and nucleocapsid protein 7 (NCp7) simultaneously. Among them, the most effective compound 7c was found to inhibit HIV-1 wild-type (WT) strain at double-digit nanomolar concentration (EC50 = 42 nM) in MT-4 cells, and sub-micromole (EC50 = 0.308 μM) to inhibit HIV-1 NL4-3 strain in TZM-bl cells. This is a significant improvement over the parent drug MT. In addition, it showed moderate inhibitory potency (EC50 = 1.329 μM) against the HIV-1 K103N/Y181C double mutant strain (MT-4 cells). The metabolic stability in human plasma of compound 7c indicated that it can release the active forms of the parent drugs MT and AZT in a linear time-independent manner and turn out to be a potential prodrug.

Full Text

Duke Authors

Cited Authors

  • Sun, S; Huang, B; Li, Z; Wang, Z; Sun, L; Gao, P; Kang, D; Chen, C-H; Lee, K-H; Daelemans, D; De Clercq, E; Pannecouque, C; Zhan, P; Liu, X

Published Date

  • August 15, 2020

Published In

Volume / Issue

  • 30 / 16

Start / End Page

  • 127287 -

PubMed ID

  • 32631509

Pubmed Central ID

  • 32631509

Electronic International Standard Serial Number (EISSN)

  • 1464-3405

Digital Object Identifier (DOI)

  • 10.1016/j.bmcl.2020.127287

Language

  • eng

Conference Location

  • England